Prevail Therapeutics Inc. 3 SEC Filings

Filed On	Filing
16 Dec 2020	Form 3: Tyto Acquisition Corp, 10% owner and 1 other Holds 0 shares of Common Stock, par value $0.0001 per share
11 Sep 2020	Form 3: Carson William H., Director No securities owned
03 Jun 2020	Form 3: Schwartz Kira M., General Counsel No securities owned
18 Nov 2019	Form 3: Sheng Morgan, Director No securities owned
19 Jun 2019	Form 3: Orbimed Advisors Llc, Director and 1 other Holds 2,430,000 shares of Common Stock
19 Jun 2019	Form 3: Thompson Peter A., Director Holds 2,430,000 shares of Common Stock
19 Jun 2019	Form 3: Nussbaum Ran, Director Holds 1,576,881 shares of Common Stock
19 Jun 2019	Form 3: Nader Francois, Director
19 Jun 2019	Form 3: Gordon Carl L, Director Holds 2,430,000 shares of Common Stock
19 Jun 2019	Form 3: Adams Timothy M, Director
19 Jun 2019	Form 3: Sevigny Jeffrey, Chief Medical Officer
19 Jun 2019	Form 3: Minkow Emily, Chief Business Officer
19 Jun 2019	Form 3: Kaplan Brett, Chief Financial Officer
19 Jun 2019	Form 3: Hefti Franz, Chief Development Officer
19 Jun 2019	Form 3: Dai Yong, Chief Technology Officer
19 Jun 2019	Form 3: Abeliovich Asa, Director Holds 2,349,000 shares of Common Stock

Comments